Sintx Technologies, Inc. (SINT)
USD 2.01
(-19.6%)
USD 2.01
(-19.6%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 15.36 Million USD | -2.59% |
| 2022 | 15.77 Million USD | -27.78% |
| 2021 | 21.84 Million USD | -28.27% |
| 2020 | 30.44 Million USD | 232.86% |
| 2019 | 9.14 Million USD | -20.56% |
| 2018 | 11.51 Million USD | -21.35% |
| 2017 | 14.64 Million USD | -44.25% |
| 2016 | 26.26 Million USD | -27.96% |
| 2015 | 36.45 Million USD | -23.39% |
| 2014 | 47.58 Million USD | 38.62% |
| 2013 | 34.32 Million USD | 2.61% |
| 2012 | 33.45 Million USD | -45.35% |
| 2011 | 61.22 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 17.56 Million USD | 14.29% |
| 2024 Q2 | 15.29 Million USD | -12.9% |
| 2023 Q3 | 15.51 Million USD | -18.78% |
| 2023 Q1 | 22.65 Million USD | 43.61% |
| 2023 Q2 | 19.09 Million USD | -15.69% |
| 2023 Q4 | 15.36 Million USD | -0.95% |
| 2023 FY | 15.36 Million USD | -2.59% |
| 2022 FY | 15.77 Million USD | -27.78% |
| 2022 Q4 | 15.77 Million USD | 8.31% |
| 2022 Q1 | 18.88 Million USD | -13.54% |
| 2022 Q3 | 14.56 Million USD | -16.75% |
| 2022 Q2 | 17.49 Million USD | -7.36% |
| 2021 Q2 | 26.41 Million USD | -7.91% |
| 2021 Q4 | 21.84 Million USD | -12.18% |
| 2021 FY | 21.84 Million USD | -28.27% |
| 2021 Q3 | 24.86 Million USD | -5.86% |
| 2021 Q1 | 28.68 Million USD | -5.79% |
| 2020 Q1 | 15.36 Million USD | 67.96% |
| 2020 FY | 30.44 Million USD | 232.86% |
| 2020 Q2 | 24.58 Million USD | 60.03% |
| 2020 Q4 | 30.44 Million USD | -6.7% |
| 2020 Q3 | 32.63 Million USD | 32.74% |
| 2019 Q4 | 9.14 Million USD | -13.69% |
| 2019 FY | 9.14 Million USD | -20.56% |
| 2019 Q3 | 10.59 Million USD | -6.02% |
| 2019 Q2 | 11.27 Million USD | 9.94% |
| 2019 Q1 | 10.25 Million USD | -10.92% |
| 2018 Q3 | 14.39 Million USD | -36.32% |
| 2018 Q4 | 11.51 Million USD | -20.02% |
| 2018 FY | 11.51 Million USD | -21.35% |
| 2018 Q1 | 14.81 Million USD | 1.2% |
| 2018 Q2 | 22.6 Million USD | 52.57% |
| 2017 Q3 | 20.6 Million USD | -9.05% |
| 2017 Q1 | 26.08 Million USD | -0.69% |
| 2017 FY | 14.64 Million USD | -44.25% |
| 2017 Q4 | 14.64 Million USD | -28.93% |
| 2017 Q2 | 22.65 Million USD | -13.16% |
| 2016 Q3 | 31.43 Million USD | 14.29% |
| 2016 Q4 | 26.26 Million USD | -16.46% |
| 2016 FY | 26.26 Million USD | -27.96% |
| 2016 Q1 | 31.08 Million USD | -14.74% |
| 2016 Q2 | 27.5 Million USD | -11.51% |
| 2015 Q4 | 36.45 Million USD | -1.99% |
| 2015 Q2 | 39.97 Million USD | -8.45% |
| 2015 Q3 | 37.19 Million USD | -6.95% |
| 2015 Q1 | 43.65 Million USD | -8.25% |
| 2015 FY | 36.45 Million USD | -23.39% |
| 2014 Q2 | 43.33 Million USD | -1.18% |
| 2014 Q3 | 42.34 Million USD | -2.26% |
| 2014 Q4 | 47.58 Million USD | 12.36% |
| 2014 FY | 47.58 Million USD | 38.62% |
| 2014 Q1 | 43.84 Million USD | 27.74% |
| 2013 Q4 | 34.32 Million USD | -3.49% |
| 2013 Q2 | 28.87 Million USD | 0.0% |
| 2013 Q1 | - USD | -100.0% |
| 2013 FY | 34.32 Million USD | 2.61% |
| 2013 Q3 | 35.56 Million USD | 23.2% |
| 2012 Q4 | 33.45 Million USD | 0.0% |
| 2012 FY | 33.45 Million USD | -45.35% |
| 2011 FY | 61.22 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | 51.014% |
| BrainsWay Ltd. | 62.97 Million USD | 75.6% |
| Cerus Corporation | 197.74 Million USD | 92.23% |
| Envoy Medical, Inc. | 7.64 Million USD | -101.113% |
| electroCore, Inc. | 16.38 Million USD | 6.237% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -99.753% |
| IceCure Medical Ltd | 16.41 Million USD | 6.368% |
| Inogen, Inc. | 326.19 Million USD | 95.29% |
| OrthoPediatrics Corp. | 449.58 Million USD | 96.582% |
| Lucid Diagnostics Inc. | 27.27 Million USD | 43.656% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | 7.323% |
| MaxCyte, Inc. | 268.27 Million USD | 94.273% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -89.754% |
| Nexalin Technology, Inc. | 3.63 Million USD | -323.055% |
| Orthofix Medical Inc. | 925.31 Million USD | 98.339% |
| PAVmed Inc | 33.11 Million USD | 53.607% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 89.289% |
| RxSight, Inc. | 182.55 Million USD | 91.583% |
| Sight Sciences, Inc. | 166.65 Million USD | 90.78% |
| SI-BONE, Inc. | 230.42 Million USD | 93.332% |
| TELA Bio, Inc. | 78.04 Million USD | 80.313% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 93.901% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -43.197% |
| Acutus Medical, Inc. | 53.96 Million USD | 71.525% |
| Talis Biomedical Corporation | 98.34 Million USD | 84.376% |
| Spectral AI, Inc. | 10.69 Million USD | -43.706% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 92.973% |
| CVRx, Inc. | 115.22 Million USD | 86.666% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | 73.807% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -393.218% |
| Bioventus Inc. | 810.91 Million USD | 98.105% |
| Venus Concept Inc. | 93.65 Million USD | 83.594% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | 40.272% |
| LivaNova PLC | 2.42 Billion USD | 99.368% |
| 908 Devices Inc. | 202.98 Million USD | 92.43% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 98.092% |
| Nemaura Medical Inc. | 14.56 Million USD | -5.505% |
| NeuroPace, Inc. | 107.65 Million USD | 85.727% |
| LENSAR, Inc. | 69.58 Million USD | 77.919% |
| Apyx Medical Corporation | 79.24 Million USD | 80.61% |
| Cutera, Inc. | 346.29 Million USD | 95.563% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | 63.431% |
| BioSig Technologies, Inc. | 1.79 Million USD | -754.561% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 94.323% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | 63.983% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 99.594% |
| Axonics, Inc. | 719.92 Million USD | 97.866% |
| Outset Medical, Inc. | 313.8 Million USD | 95.104% |
| IRIDEX Corporation | 34.43 Million USD | 55.381% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 96.204% |
| IRadimed Corporation | 92.15 Million USD | 83.327% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -192.444% |
| INVO Bioscience, Inc. | 20.88 Million USD | 26.44% |
| Telesis Bio, Inc. | 70.41 Million USD | 78.178% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 90.029% |
| Varex Imaging Corporation | 1.24 Billion USD | 98.77% |
| Quipt Home Medical Corp. | 247.4 Million USD | 93.79% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -65.038% |
| Pulmonx Corporation | 178.95 Million USD | 91.414% |
| Dynatronics Corporation | 25.94 Million USD | 40.768% |
| Modular Medical, Inc. | 13.8 Million USD | -11.284% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -43.237% |
| Semler Scientific, Inc. | 78.06 Million USD | 80.318% |
| InMode Ltd. | 863.28 Million USD | 98.22% |
| Bruker Corporation | 4.24 Billion USD | 99.638% |
| Cytosorbents Corporation | 53.26 Million USD | 71.151% |
| DexCom, Inc. | 6.26 Billion USD | 99.755% |
| Align Technology, Inc. | 6.08 Billion USD | 99.747% |
| Viveve Medical, Inc. | 25.91 Million USD | 40.705% |
| ZimVie Inc. | 1.2 Billion USD | 98.725% |
| Movano Inc. | 9.42 Million USD | -63.093% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 96.913% |
| Nexalin Technology, Inc. | 3.63 Million USD | -323.055% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | 73.807% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 98.387% |
| Profound Medical Corp. | 43.68 Million USD | 64.829% |
| Insulet Corporation | 2.58 Billion USD | 99.406% |
| enVVeno Medical Corporation | 48.63 Million USD | 68.408% |
| Surmodics, Inc. | 185.73 Million USD | 91.727% |
| iCAD, Inc. | 41.41 Million USD | 62.903% |
| Nuwellis, Inc. | 9.77 Million USD | -57.267% |
| Biotricity, Inc. | 5.94 Million USD | -158.556% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 96.453% |
| Aethlon Medical, Inc. | 8.24 Million USD | -86.333% |
| InspireMD, Inc. | 47.64 Million USD | 67.75% |
| PAVmed Inc. | 33.11 Million USD | 53.607% |
| BIOLASE, Inc. | 35.1 Million USD | 56.226% |
| Beyond Air, Inc. | 56.96 Million USD | 73.025% |
| FONAR Corporation | 214.24 Million USD | 92.828% |
| AxoGen, Inc. | 196.82 Million USD | 92.194% |
| Vivani Medical, Inc. | 45.79 Million USD | 66.45% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 94.541% |
| Inari Medical, Inc. | 674.23 Million USD | 97.721% |
| UFP Technologies, Inc. | 404.13 Million USD | 96.198% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | 34.334% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -61.684% |
| Tenon Medical, Inc. | 6.34 Million USD | -142.159% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -63.336% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 85.176% |
| AdaptHealth Corp. | 4.61 Billion USD | 99.667% |
| NanoVibronix, Inc. | 6.67 Million USD | -130.222% |
| Quanterix Corporation | 425.01 Million USD | 96.385% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -65.038% |
| Sensus Healthcare, Inc. | 53.72 Million USD | 71.402% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 99.12% |
| TransMedics Group, Inc. | 706.04 Million USD | 97.824% |
| ReWalk Robotics Ltd. | 63.19 Million USD | 75.685% |
| NeuroMetrix, Inc. | 21.42 Million USD | 28.283% |
| Hyperfine, Inc. | 94.19 Million USD | 83.689% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 94.28% |
| Biomerica, Inc. | 9.25 Million USD | -66.036% |
| Bone Biologics Corporation | 3.73 Million USD | -311.075% |
| AVITA Medical, Inc. | 144.33 Million USD | 89.355% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -215.598% |
| Silk Road Medical, Inc | 265.3 Million USD | 94.209% |